FFSC-1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFFSC-1
Drug Alias Nameendothelial/inducible nitric oxide synthase inhibitor (Dharma Biomedical)eNOS/iNOS inhibitor (Dharma Biomedical)FFSC-1
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionNitric-oxide synthase, endothelial inhibitorsNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducibleNitric-oxide synthase, endothelial
Therapy Area/IndicationsInflammationMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDharma Biomedical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDharma Biomedical
Active IndicationsN/A
Inactive IndicationsInflammationMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A